News and Events

How the Pfizer-BioNTech Vaccine Works

The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2, the generic name tozinameran or the brand name Comirnaty. A clinical trial demonstrated that the vaccine has an efficacy rate of 95 percent in preventing Covid-19.

Read full article on nytimes.com.

IBC Finland ry
c/o Clic Innovation Ltd
Eteläranta 10, 5th floor
FI-00130 Helsinki

IBC Finland builds novel biotechnology solutions and products through project cooperation between companies and research institutes. We offer industry the opportunity to achieve sustainable processing and production of biobased products, chemicals, materials and fuels, from renewable raw materials using biotechnology.

Read about our Privacy Policy.